When the coronavirus disease began to spread widely in the United States, ACCC members on the frontlines of the pandemic came together as a community to share their perspective and lessons learned by participating in ACCC webcasts, mini-podcasts, and blog posts. The educational resources included in this COVID-19 Resource Center represent the expertise, dedication, and generosity of ACCC members across the nation who have been deeply involved in caring for patients and establishing protocols for virus response since March 2020.
On January 7, 2021, U.S. Department of Health and Human Services (HHS) Secretary Alex Azar signed an extension of the COVID-19 public health emergency (PHE) designation until April 21, 2021. ACCC resources from the pandemic's acute phase and pre-vaccination phase are accessible to help cancer programs and practices that still face many pressing issues related to COVID-19.
combatCOVID.hhs.gov provides important information and links to access the most current treatment guidelines and inpatient and outpatient clinical trials.
The LUNGevity Foundation's COVID-19 Vaccine FAQs provides information from trusted sources (in English and Spanish) for informed patient-provider conversations about getting a COVID-19 vaccine.
In the wake of COVID-19, seismic changes have pushed cancer care providers to continue to prove their resiliency and ability to quickly adapt to change. View on-demand sessions from the ACCC 47th Annual Meeting & Cancer Center Business Summit to hear real-world examples from institutions that have used the opportunity created by this pandemic to forge a new path forward.
Explore the agenda and the opportunity to register at reduced rates.
The ACCC Financial Advocacy Network developed the COVID-19 Financial Advocacy Resources hub to help cancer programs and practices to stay informed on rapidly changing updates to financial assistance programs and insurance coverage in response to the public health emergency. This resource will be reviewed and updated weekly.
Adoption & Expansion of Telehealth Solutions addresses the immediate and ongoing needs of cancer programs and practices that want to implement, integrate, and expand their telehealth services to optimize patient care during the current public health emergency and beyond. Through this effort, ACCC will help guide members of the multidisciplinary team in the areas of rapid response, policy rules and regulations, team-based telehealth delivery, technology needs, and actionable blueprints to build new telehealth solutions.
An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.
COVID-19 has impacted how providers are dispensing multiple myeloma medications and providing care to patients during the pandemic. Learn how to identify those effects to help mitigate them and implement strategies to improve telehealth medicine during the pandemic.
Join Charles Saunders, MD, Chief Executive Officer, and Jennifer Webster, MS, Vice President of Analytics, IntegraConnect, as they present an overview of the current landscape of patient levels and services at cancer programs. (July 10, 2020)
Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client & Corporate Resources, Revenue Cycle Coding Strategies, highlights what your cancer program needs to know by discussing the changes to telehealth services, supervision, provider-based designations, and coding for services. (July 10, 2020)
Join Raju K. Vaddepally, MD, Yuma Regional Medical Center Cancer Center, to discuss strategies for sustaining a robust clinical trials program in uncertain times and how to increase the relevance of research to vulnerable and underserved patients. (June 26, 2020)
See what members are discussing in the COVID-19 Forum, exclusively for ACCC Members. (Requires Login)
We sat down with ACCC President Krista Nelson, on how her personal experiences during the pandemic—and those of her colleagues and patients—deeply impacted her and influenced the development of her 2021-2022 ACCC President’s Theme.
Explores the impact of the COVID-19 pandemic on the financial health of cancer programs and practices across the country, from lower patient volume and screening interventions and decreased revenue streams.
We'll discuss the telehealth regulatory and policy changes enacted during the COVID-19 pandemic, what may change in 2021, and what’s likely to remain the same regarding the reimbursement of remote care.
Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.
Learn how the role of caregivers has changed during the pandemic, and how the cancer team can provide caregivers with guidance on taking care of patients with cancer.
We explore how patients are dealing with the "new normal,” and how oncology social workers, psychologists, and psychiatrists are working to help them through an unprecedented time.
Learn how some cancer programs are finding creative ways to engage patients and adapt screening programs during these difficult times.
Krista Nelson, ACCC President 2021-22, shares how Providence Cancer Institute has made staff resiliency and morale a priority during the COVID-19 pandemic.
The ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) is aimed to help ASCO examine the evidence on the effect of COVID-19 on patients with cancer. The ASCO Registry collects baseline and longitudinal data on patients with cancer and COVID-19 and plans to deliver periodic reports with key findings that can influence future care. The greater diversity and number of patients the Registry represents, the more we can learn from this unique experience in cancer care. Join the Registry.
ACCC launched a COVID-19 Resource Center in March 2020 to offer education and tools to community practitioners working directly on the frontlines.
Despite a century-long history and a substantial body of recent empirical evidence that attests to its clinical and economic effectiveness and improved access, telemedicine has yet to become a routine part of clinical practice for the majority of clinicians. If used appropriately, it can serve as an effective substitute for in-person care which does not require physical examination in nearly all facets of the medical care process, including prevention, diagnosis, treatment, monitoring, and follow-up.
SARS-CoV-2 and the resulting respiratory tract infection COVID-19 has upended our society and forcefully changed the way we care for patients. Since the emergence of the virus in early 2020, there have been questions surrounding the risk posed to patients with a cancer diagnosis and the safety of anticancer therapies.
Oncology Professionals Look Back and Ahead at Cancer Care After A Year of COVID-19
March 12, 2021
Cancer Care From the COVID-19 Frontlines: “Flying by the Seat of Our Pants”
March 7, 2021
The COVID-19 Pandemic is Increasing Cancer Deaths. Here’s What Needs to Be Done to Reverse It
February 2, 2021
The COVID-19 Pandemic Has Disrupted Cancer Trials
January 29, 021
COVID-19 and the Rise in Cancer Mortality
January 5, 2021
Page last updated Feb 11, 2021